news TEMPOL drug shows promise as antiviral treatment for COVID-19 8 June 2021 | By Victoria Rees (Drug Target Review) The experimental drug TEMPOL has demonstrated antiviral activity against COVID-19 in a pre-clinical study in cell cultures.